Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -738 | -50,860 | -36,956 | -25,675 | -12,170 |
| Depreciation Amortization | 7 | 324 | 245 | 163 | 82 |
| Accounts payable and accrued liabilities | 16 | 898 | -524 | 824 | -943 |
| Other Working Capital | 319 | 3,075 | 172 | 2,082 | -385 |
| Other Operating Activity | -9 | 5,866 | 5,606 | 2,548 | 2,643 |
| Operating Cash Flow | $-404 | $-40,697 | $-31,457 | $-20,057 | $-10,774 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -189 | -161 | -106 | -89 |
| Investing Cash Flow | $N/A | $-189 | $-161 | $-106 | $-89 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 5,000 | 5,000 | 5,000 | N/A |
| Debt Repayment | -4 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 1,056 | 17,554 | 17,526 | 17,479 | 55 |
| Financing Cash Flow | $1,053 | $22,554 | $22,526 | $22,479 | $55 |
| Beginning Cash Position | 176 | 106,399 | 106,399 | 106,399 | 106,399 |
| End Cash Position | 824 | 88,068 | 97,307 | 108,715 | 95,591 |
| Net Cash Flow | $648 | $-18,331 | $-9,092 | $2,316 | $-10,808 |
| Free Cash Flow | |||||
| Operating Cash Flow | -404 | -40,697 | -31,457 | -20,057 | -10,774 |
| Capital Expenditure | N/A | -189 | -161 | -106 | -89 |
| Free Cash Flow | -404 | -40,886 | -31,618 | -20,163 | -10,863 |